These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 26041962)

  • 21. Hepatic encephalopathy: Ever closer to its big bang.
    Souto PA; Marcotegui AR; Orbea L; Skerl J; Perazzo JC
    World J Gastroenterol; 2016 Nov; 22(42):9251-9256. PubMed ID: 27895414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death.
    Angelova PR; Kerbert AJC; Habtesion A; Hall A; Abramov AY; Jalan R
    JHEP Rep; 2022 Aug; 4(8):100510. PubMed ID: 35845295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure.
    Chastre A; Bélanger M; Nguyen BN; Butterworth RF
    Liver Int; 2014 Mar; 34(3):353-61. PubMed ID: 23910048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal.
    Albrecht J; Zielińska M; Norenberg MD
    Biochem Pharmacol; 2010 Nov; 80(9):1303-8. PubMed ID: 20654582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same.
    Shawcross DL; Olde Damink SW; Butterworth RF; Jalan R
    Metab Brain Dis; 2005 Sep; 20(3):169-79. PubMed ID: 16167195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure.
    Bernal W; Hall C; Karvellas CJ; Auzinger G; Sizer E; Wendon J
    Hepatology; 2007 Dec; 46(6):1844-52. PubMed ID: 17685471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease.
    Ochoa-Sanchez R; Rose CF
    J Clin Exp Hepatol; 2018 Sep; 8(3):262-271. PubMed ID: 30302043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy.
    Görg B; Schliess F; Häussinger D
    Arch Biochem Biophys; 2013 Aug; 536(2):158-63. PubMed ID: 23567841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.
    Jover-Cobos M; Noiret L; Lee K; Sharma V; Habtesion A; Romero-Gomez M; Davies N; Jalan R
    J Hepatol; 2014 Mar; 60(3):545-53. PubMed ID: 24512823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute liver failure in rats activates glutamine-glutamate cycle but declines antioxidant enzymes to induce oxidative stress in cerebral cortex and cerebellum.
    Singh S; Mondal P; Trigun SK
    PLoS One; 2014; 9(4):e95855. PubMed ID: 24755687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis.
    Srivastava A; Chaturvedi S; Gupta RK; Malik R; Mathias A; Jagannathan NR; Jain S; Pandey CM; Yachha SK; Rathore RKS
    J Hepatol; 2017 Mar; 66(3):528-536. PubMed ID: 27815224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy.
    Luo M; Liu H; Hu SJ; Bai FH
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):665-73. PubMed ID: 26216028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of Nrf2/HO-1 and mitigation of NF-κB/MAPK signaling pathways.
    Khalil HMA; Eliwa HA; El-Shiekh RA; Al-Mokaddem AK; Hassan M; Tawfek AM; El-Maadawy WH
    J Ethnopharmacol; 2021 Sep; 277():114141. PubMed ID: 33905819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ammonia neurotoxicity: role of the mitochondrial permeability transition.
    Rama Rao KV; Jayakumar AR; Norenberg DM
    Metab Brain Dis; 2003 Jun; 18(2):113-27. PubMed ID: 12822830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy.
    Bosoi CR; Rose CF
    Metab Brain Dis; 2013 Jun; 28(2):175-8. PubMed ID: 23124921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced-acute liver failure: A critical appraisal of the thioacetamide model for the study of hepatic encephalopathy.
    Sepehrinezhad A; Shahbazi A; Sahab Negah S; Joghataei MT; Larsen FS
    Toxicol Rep; 2021; 8():962-970. PubMed ID: 34026559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.
    Mondal P; Trigun SK
    Metab Brain Dis; 2014 Dec; 29(4):1007-15. PubMed ID: 24807590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatic encephalopathy].
    Hilgard P; Gerken G
    Med Klin (Munich); 2004 Oct; 99(10):591-602. PubMed ID: 15490075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ammonia-lowering strategies for the treatment of hepatic encephalopathy.
    Rose CF
    Clin Pharmacol Ther; 2012 Sep; 92(3):321-31. PubMed ID: 22871998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.
    Shawcross DL; Shabbir SS; Taylor NJ; Hughes RD
    Hepatology; 2010 Mar; 51(3):1062-9. PubMed ID: 19890967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.